$ENHA

Enhanced Group (ENHA) reported nearly tripled gross revenue in Q3 2026 for its Live Enhanced segment, despite flat marketing spend. The company announced early access sign-ups for Enhanced OS, a personalized health platform launching in January 2027. Enhanced also plans to acquire DEAG, expecting combined 2027 revenues of $670 million and positive adjusted EBITDA of $26 million. The company aims for Live Enhanced profitability by year-end and sports business break-even in 2027.

Enhanced Group Inc. (NYSE:ENHA) launched Enhanced OS, an AI platform for personalized health protocols, with early access starting Wednesday. The platform uses diagnostics, medical records, and wearable data to generate tailored recommendations. Full launch is planned for January 2027, with prescription product integration. The company developed the approach through a clinical study with athletes.

Enhanced Group (ENHA) reported Q3 2026 revenue of $3.3M, down from $17.7M in Q2 and none a year earlier. Net loss was $13.5M, improved from $61.9M in Q2 and $5.9M a year earlier. The company expects $670M in 2027 revenue after the proposed DEAG acquisition.

Enhanced Group Inc. (ENHA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Enhanced Group Inc. Reports Third Quarter 2026 Results Definitive agreement signed to acquire ~77% of DEAG Deutsche Entertainment AG as announced on November 5, 2026 Stake in DEAG to be acquired via an all-stock transaction at 5.3x FY2027E Adjusted EBITDA (1)(3) , with combined 2

Enhanced Group Inc. (ENHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Enhanced Group (NYSE: ENHA) to Acquire Controlling Interest in Pan-European Live Entertainment Company DEAG, Creating a Global Platform for the Experience Economy, And Conducting Concurrent $15 Million PIPE Acquisition creates a global sports and live entertainment platform for i

Enhanced Group (ENHA) is nearing a deal to acquire DEAG Deutsche Entertainment AG (LOUn), according to Bloomberg. The deal would give ENHA 75% of DEAG in exchange for newly issued shares. DEAG shares surged 11% in Hamburg trading, while ENHA rose 0.8% in U.S. premarket. The combined entity is projected to generate $670M in revenue and $26M in adjusted earnings next year.

Enhanced Group Inc. (ENHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On October 31, 2026, Enhanced Group Inc. (the “Company”) entered into an Amendment No. 1 to Transaction Support Agreement (each, a “TSA Amendment”) with each of (i) Enhanced Holdings LP (“Enhanced Holdings”), the Company's cont

Enhanced Group (ENHA) has expanded its peptide offerings to include six new compounds, available only by prescription after clinician evaluation. The company emphasizes quality, clinical standards, and regulatory compliance. CEO Maximilian Martin highlights the importance of medical supervision and quality-controlled ingredients. Enhanced plans to refine protocols and may expand access as regulations develop. The company is listed on the NYSE under the ticker ENHA.

Enhanced Group (ENHA) announced that key shareholders, including Apeiron Investment Group and CEO Maximilian Martin, extended their lock-up period until May 2027. This reduces the number of shares released on November 8, 2026, from 5.2 million to 2.1 million. Apeiron also acquired additional shares, increasing its stake. Post-November 2026, only 6.1 million of the 13.7 million shares will be freely tradable, with a significant portion held by Apeiron and other shareholders.

Enhanced Group (ENHA) completed a reverse stock split, combining 10 shares into 1, with no change in ownership stakes. Trading begins Oct 29, 2026, under the same ticker but new CUSIP. Post-split, 13.68M Class A and 25.88M Class B shares are outstanding. Shareholders' holdings were adjusted automatically. Enhanced is a sports and performance products company.